Community Oncology Connections™: Advancing Precision Care in HER2-Positive Gastroesophageal Adenocarcinomas: A Collective Curriculum on the Integration of Novel Bispecific Antibody Therapy
Wednesday, September 2, 2026
12:15 PM - 1:15 PM CT
In this series of live, virtual webcasts, experts in the management of esophagogastric adenocarcinoma discuss the evaluation and treatment of HER2-positive disease across the treatment continuum.
Community Oncology Connections™: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC
Wednesday, October 7, 2026
12:15 PM - 1:15 PM CT
This program will be delivered as a series of 8 live, CME-certified virtual meetings in collaboration with ACCC-affiliated Oncology State Societies, supported by an enduring online activity.
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer
Wednesday, November 4, 2026
12:15 PM - 1:15 PM CT
This online, CME-certified Community Oncology Connections – How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer, will bring together expert faculty to review the key recent findings and discuss their potential implications for community oncologists.